Yellow fever/Japanese encephalitis chimeric viruses: construction and biological properties
about
A Rapid and Improved Method to Generate Recombinant Dengue Virus Vaccine CandidatesDengue Fever: Causes, Complications, and Vaccine StrategiesThe yellow fever 17D virus as a platform for new live attenuated vaccinesJapanese encephalitis: the virus and vaccinesRecovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse VirulenceRecombinant yellow fever viruses are effective therapeutic vaccines for treatment of murine experimental solid tumors and pulmonary metastases.Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys.Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5' noncoding region and nonstructural proteins 1 and 3Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccineRecombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primatesChimeric yellow fever/dengue virus as a candidate dengue vaccine: quantitation of the dengue virus-specific CD8 T-cell responseMolecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).Neuroadapted yellow fever virus 17D: genetic and biological characterization of a highly mouse-neurovirulent virus and its infectious molecular cloneConstruction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine.Attenuation of Murray Valley encephalitis virus by site-directed mutagenesis of the hinge and putative receptor-binding regions of the envelope protein.Tick-Borne Langat/Mosquito-Borne Dengue Flavivirus Chimera, a Candidate Live Attenuated Vaccine for Protection against Disease Caused by Members of the Tick-Borne Encephalitis Virus Complex: Evaluation in Rhesus Monkeys and in MosquitoesWest Nile virus/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacySingle mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines.Yellow fever virus replicons as an expression system for hepatitis C virus structural proteinsYellow Fever Virus/Dengue-2 Virus and Yellow Fever Virus/Dengue-4 Virus Chimeras: Biological Characterization, Immunogenicity, and Protection against Dengue Encephalitis in the Mouse ModelStable High-Producer Cell Clone Expressing Virus-Like Particles of the Japanese Encephalitis Virus E Protein for a Second-Generation Subunit VaccineProduction of Pseudoinfectious Yellow Fever Virus with a Two-Component GenomeBroadening the horizons for yellow feverEvaluation of the Langat/dengue 4 chimeric virus as a live attenuated tick-borne encephalitis vaccine for safety and immunogenicity in healthy adult volunteersJE Nakayama/JE SA14-14-2 virus structural region intertypic viruses: Biological properties in the mouse model of neuroinvasive diseaseProduction and characterization of vaccines based on flaviviruses defective in replicationNeuroadapted Yellow Fever Virus 17D: Determinants in the Envelope Protein Govern Neuroinvasiveness for SCID MiceEvaluation of St. Louis encephalitis virus/dengue virus type 4 antigenic chimeric viruses in mice and rhesus monkeysEvaluation of Chimeric Japanese Encephalitis and Dengue Viruses for Use in Diagnostic Plaque Reduction Neutralization TestsVaccines: the Fourth CenturyEfficient, trans-complementing packaging systems for chimeric, pseudoinfectious dengue 2/yellow fever virusesIssues related to recent dengue vaccine development.Flaviviruses, an expanding threat in public health: focus on dengue, West Nile, and Japanese encephalitis virus.Persistence of Wild-Type Japanese Encephalitis Virus Strains Cross-Neutralization 5 Years After JE-CV ImmunizationJapanese encephalitis virus vaccine candidates generated by chimerization with dengue virus type 4A molecularly cloned, live-attenuated japanese encephalitis vaccine SA14-14-2 virus: a conserved single amino acid in the ij Hairpin of the Viral E glycoprotein determines neurovirulence in miceSequential immunization with heterologous chimeric flaviviruses induces broad-spectrum cross-reactive CD8+ T cell responses.Dengue type 4 live-attenuated vaccine viruses passaged in vero cells affect genetic stability and dengue-induced hemorrhaging in miceStructural gene (prME) chimeras of St Louis encephalitis virus and West Nile virus exhibit altered in vitro cytopathic and growth phenotypes.Evaluation of three commercially available Japanese encephalitis virus IgM enzyme-linked immunosorbent assays.
P2860
Q24282617-E92EE191-2838-4D02-9818-E013702418E9Q26700082-D3D38CE7-536C-4B33-8C06-C8395CB66B73Q26865102-EE11A656-FBC9-494F-BF59-D29A26F939F5Q27010434-EED06EE2-ADE1-4739-A742-C00BD51D333AQ27469118-E713B128-C013-487C-BAB5-3CB13A288719Q27469314-9A8B7D81-C0DD-42A6-99CC-B44A3B46CDF7Q27469631-BFD61035-4E0E-4E14-82BF-F9755EE1A4E9Q27469644-843AEFFA-9534-4F6B-B7CF-A9D1B902AC70Q27469646-AD3994C0-9116-4E62-BE80-ED3437C40190Q27469664-A40BD5DB-83A5-4DAE-A1F8-76B2277E8C09Q27469691-5DB06625-EDEC-4C9F-8BEB-C32273EFA0C8Q27469763-86CCAFED-D625-4ED4-B6D4-BB741905FD48Q27469879-A67DB576-BC22-4CE1-8704-848592C1AC95Q27469921-30379A3A-8E2C-472D-B5A0-379F370A8CACQ27469932-A5EB0781-46CF-4918-B0E3-054EF3938EE3Q27469955-3D3CA80C-1127-4BD1-BD85-927CFDFAC666Q27471660-438F0DB8-F6D4-4478-8716-6C7CC4AE408EQ27472841-20276709-0A6C-41EA-9C61-47A49E54C8BDQ27473075-70CE2AF0-8D38-4485-B71D-EDB6DC149C27Q27473317-1E02EE19-8C4D-4106-9F8B-CC8AC95FA707Q27477712-E37E9DE5-0C27-4255-8C77-AABBCF31F320Q27484992-D811A308-F362-49D8-9762-3952448F2520Q27485206-5FC9E355-626D-4A86-80E6-D50434898908Q27485433-4FF5190B-9E01-4B2B-859E-038B0DE5A7B8Q27485478-327B1106-B1B3-4E91-9080-3E65B522B8E5Q27486374-31A02703-6926-4394-A730-BC6D634E6EF6Q27486896-71ECB999-A756-4A13-B202-6B30F1A25C37Q27487013-B52908C5-8B0D-43A4-B972-25C9073A1C0CQ27488878-09F4F5EF-8972-4FB6-A3B6-0F131DC50922Q27490454-C4012E0D-C1C0-496F-8020-DA04CA877DD5Q27491035-66F79CCE-A75B-4F82-87A5-059E8C914675Q30395396-83BA38F4-D821-4B11-A149-C948EC258E1BQ30857727-3E2CA63B-A34C-49AE-BD74-4B1CAAB741ECQ33712740-448FFC6D-2264-40F3-A0E4-E7C6B547DEB9Q33852635-2A370E54-93C9-4490-84AF-02E21A8A0886Q33982616-AF70AFF9-5DF9-4821-B1BF-F9A2BEB7A0E4Q33992835-2FDBA248-7DAA-4ED4-9A44-618C3F92642CQ34066921-37704556-F625-44B8-8EC8-D111D53F7A4CQ34218526-C48AE427-8092-4684-9EAC-4C23770BADB3Q34240178-7C98FEBF-0E3F-4861-9D77-D80092F577AD
P2860
Yellow fever/Japanese encephalitis chimeric viruses: construction and biological properties
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Yellow fever/Japanese encephal ...... tion and biological properties
@ast
Yellow fever/Japanese encephal ...... tion and biological properties
@en
Yellow fever/Japanese encephal ...... tion and biological properties
@nl
type
label
Yellow fever/Japanese encephal ...... tion and biological properties
@ast
Yellow fever/Japanese encephal ...... tion and biological properties
@en
Yellow fever/Japanese encephal ...... tion and biological properties
@nl
prefLabel
Yellow fever/Japanese encephal ...... tion and biological properties
@ast
Yellow fever/Japanese encephal ...... tion and biological properties
@en
Yellow fever/Japanese encephal ...... tion and biological properties
@nl
P2093
P2860
P921
P3181
P1433
P1476
Yellow fever/Japanese encephal ...... tion and biological properties
@en
P2093
Chambers TJ
Nestorowicz A
P2860
P304
P3181
P577
1999-04-01T00:00:00Z